# To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

> **NCT00143338** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Inhaled insulin

## Key facts

- **NCT ID:** NCT00143338
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143338, "To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00143338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*